Your only mesothelioma treatments news source!
Click on each item to read full story.

 
Asbestos Awareness Week: Can We Counteract Decades of Damage with Research?
read story
During the first week of April, the Mesothelioma Applied Research Foundation (Meso Foundation) will observe Asbestos Awareness Week while raising awareness of the deep damage inflicted by asbestos’ use and the overdue need for life-saving treatments and a cure for those who have already developed, or who will develop, mesothelioma. Mesothelioma is a cancer known to be caused by exposure to ...
 
Why insurers should fund medical research
read story
Should the insurance industry stump up funds?
 
Mesothelioma Support, Professional Advice and More Can Be Found on New Website Mesothelioma.net
read story
The Newly-Launched Website Offers Much-Needed Help and Hope for Victims of Mesothelioma and their Loved Ones (PRWeb March 20, 2014) Read the full story at http://www.prweb.com/releases/mesothelioma-support/meso-support/prweb11678896.htm
 
Foundation Announces Three Regional Conferences for Mesothelioma Community
read story
Following the successful conclusion of its annual Symposium, the Mesothelioma Applied Research Foundation (Meso Foundation) announced that later this year it will be the host of three regional conferences in Philadelphia, Chicago, and San Francisco, for mesothelioma patients, their families, and others interested in learning about the most up-to-date information on mesothelioma treatment. (PRWeb ...
 
Teleconference about New Drug for Mesothelioma
read story
On April 8 at 9 PM Eastern time, the Mesothelioma Applied Research Foundation (Meso Foundation) will hold a new installment of its ‘Meet the Experts’ series, featuring Dr. Joanna C. Horobin, the Chief Medical Officer at Verastem, Inc., who will discuss the company’s latest drug, defactinib, which is being developed for use in patients with pleural mesothelioma. (PRWeb March 31, 2014) Read the ...
 
Presentations from Mesothelioma Conference Now Available Online
read story
The Mesothelioma Applied Research Foundation released today videos of scientific and community sessions and speeches from the 2014 International Symposium on Malignant Mesothelioma. (PRWeb March 30, 2014) Read the full story at http://www.prweb.com/releases/2014/03/prweb11716433.htm
 
Rep. Chellie Pingree Receives Bruce Vento Hope-Builder Award for Work on Behalf of Mesothelioma Patients
read story
The Mesothelioma Applied Research Foundation (Meso Foundation) awarded Congresswomen Betty McCollum and Chellie Pingree the Bruce Vento Hope-Builder Award, for sending a letter to Dr. Harold Varmus, Director of the National Cancer Institute, to urge the National Cancer Institute to further mesothelioma research. (PRWeb March 31, 2014) Read the full story at http://www.prweb.com/releases/2014/03 ...
 
Verastem Presents Data on Cancer Stem Cell-Targeting Agents at the 2014 AACR Annual Meeting
read story
Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the presentation of scientif
 
Cancer Monthly Advises Actos Users to Know the Symptoms of Bladder Cancer
read story
In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the symptoms of bladder cancer and protect their rights if they are diagnosed. (PRWeb April 17, 2014) Read the full story at http://www.prweb.com/releases/2014/04/prweb11766224.htm
 
Cancer Monthly Warns: Actos Not the Only Drug That May Pose Bladder Cancer Risk
read story
The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWeb April 16, 2014) Read the full story at http://www.prweb.com/releases/2014/04/prweb11763969.htm